Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.

Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.

Item
http://www.wikidata.org/entity/Q37586838
Using circulating tumor cells to inform on prostate cancer biology and clinical utilityRNAi reduces expression and intracellular retention of mutant cartilage oligomeric matrix protein.GCPII imaging and cancer.Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device.Detecting circulating tumor cells: current challenges and new trends.Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine.Tailoring of chronic lymphatic leukemia therapyRNAi Therapeutics in Autoimmune Disease.Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer.2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.
P2860

Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.

Item
http://www.wikidata.org/entity/Q37586838
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.
@en
Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.
@nl
type
label
Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.
@en
Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.
@nl
prefLabel
Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.
@en
Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics.
@nl
P1433
P1476
P2093
P2860
P304
P31
P433
P478
P577
P698
P932
P1433
P1476
Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics
@en
P2093
P2860
P304
P31
P433
P478
P577
P698
P932